Today: 11 June 2026
Goldman Sachs stock slips into holiday week — what traders watch next for GS
18 January 2026
2 mins read

Goldman Sachs stock slips into holiday week — what traders watch next for GS

New York, January 18, 2026, 14:16 EST — Market closed.

  • Shares of Goldman Sachs ended Friday at $962, slipping 1.4%.
  • Bank shares slipped ahead of the long weekend, rattled by new policy proposals that fueled uncertainty.
  • Trading picks up again Tuesday as investors eye earnings reports, interest rate moves, and Washington headlines for cues.

Goldman Sachs (GS) shares ended Friday at $962, slipping 1.4% after trading in a range from $957.63 to $983.53.

The dip came as U.S. equities finished mostly flat in a jittery session ahead of the long weekend, with Wall Street closed Monday for the Martin Luther King Jr. holiday. Traders stayed cautious ahead of Friday’s monthly options expiration — contracts that set buy or sell prices on shares. Investors are also uneasy over President Donald Trump’s plan to cap credit card interest rates at 10% for one year, a move banks warn could hit profits. “Most investors will take that as a win,” said Anthony Saglimbene, chief market strategist at Ameriprise Financial, commenting on the market’s flat close. Reuters

Goldman Sachs reported Q4 earnings per share of $14.01 on Thursday, beating the $11.67 consensus estimate from analysts, according to LSEG data. The strong results were driven by a record $4.31 billion in equity trading revenue. The bank raised its quarterly dividend to $4.50 per share, with CEO David Solomon calling the M&A environment “incredibly constructive.” Stephen Biggar, a banking analyst at Argus Research, described the dividend hike as a “powerful testament” to management’s confidence. Peer Morgan Stanley also exceeded profit forecasts. Reuters

Goldman Sachs Group reported net revenues of $13.45 billion and net earnings of $4.62 billion for the fourth quarter. Full-year earnings came in at $17.18 billion. “We continue to see high levels of client engagement across our franchise and expect momentum to accelerate in 2026,” CEO Solomon said. Goldman Sachs

After a strong rally last year, the stock is now priced on follow-through: a steadier M&A pipeline, increased equity underwriting, and some recovery in leveraged finance. Goldman’s wealth and asset management division also plays a key role, providing a steady fee stream that can soften the impact when deal flow dips.

Rates are still the key factor. When the bond market steadies, trading volumes tend to drop. But a surge in yields can dampen appetite for deals and curb corporate borrowing, even though it boosts client hedging activity.

Next week shifts the spotlight. Netflix reports earnings Tuesday, marking a move past the banking sector’s results. Then on Wednesday, the Supreme Court will hear arguments in Trump’s bid to oust Federal Reserve Governor Lisa Cook, spotlighting Fed independence. “Earnings need to carry the news cycle,” said Art Hogan, chief market strategist at B Riley Wealth. Reuters

Yet the bank trade remains on edge over Washington moves. A sudden jump from policy chatter to draft legislation can spook sentiment fast, and it seldom comes in tidy, standalone chunks.

Goldman faces a key moment Tuesday, January 20, when trading restarts and investors decide if Friday’s drop sparks buying or pushes the slide further. More volatility could boost its trading desks but might also stall deal activity, leaving the stock without a clear signal.

Stock Market Today

  • PIMCO ETFs PLC Declares Key Dividend Dates for June 2026
    June 11, 2026, 10:57 AM EDT. PIMCO ETFs PLC announced important dividend-related dates: a record date on June 17, 2026, followed by a pay date on June 18, 2026. The ex-dividend date, which is the cutoff to buy the ETF to receive the dividend, is set for June 11, 2026. These dates are critical for investors tracking income and dividend payouts from PIMCO ETFs, signaling when shares must be held to qualify for dividend payments.

Latest articles

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

11 June 2026
Trulieve began NYSE trading as TRLV this week after moving from OTC/CSE, authorized a buyback of up to $50 million or 8.5 million shares, and closed its first NYSE session at $11.50, down 0.43%, before trading near $11.78 early Thursday, as investors weigh whether the uplisting and buyback will boost demand amid ongoing federal cannabis policy uncertainty.
Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
Tencent stock price: 0700.HK closes at HK$617.50 as AI push and March results date come into focus
Previous Story

Tencent stock price: 0700.HK closes at HK$617.50 as AI push and March results date come into focus

Hermes stock: why RMS.PA slid on Friday and what investors watch next week
Next Story

Hermes stock: why RMS.PA slid on Friday and what investors watch next week

Go toTop